Adaptive Biotechnologies (ADPT) Cash from Investing Activities Growth (1y) (2019 - 2026)
Adaptive Biotechnologies (ADPT) Cash from Investing Activities Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 465.38% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -1,600.38% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -2.89% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | -13.29% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 32.46% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 35.74% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -91.12% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -480.95% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -353.86% |
| 10 | Adaptive Biotechnologies | 2.66 Bn | 2.45 Bn | 52.17 Mn | -64.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.25% |
| Dec 31, 2025 | -137.31% |
| Sep 30, 2025 | 226.90% |
| Jun 30, 2025 | -43.07% |
| Mar 31, 2025 | -42.54% |
| Dec 31, 2024 | 589.71% |
| Sep 30, 2024 | -79.77% |
| Jun 30, 2024 | -84.25% |
| Mar 31, 2024 | -29.33% |
| Dec 31, 2023 | 103.29% |
| Sep 30, 2023 | -54.95% |
| Jun 30, 2023 | 686.41% |
| Mar 31, 2023 | 67.11% |
| Dec 31, 2022 | -245.13% |
| Sep 30, 2022 | 372.78% |
| Jun 30, 2022 | -88.55% |
| Mar 31, 2022 | -59.83% |
| Dec 31, 2021 | 119.77% |
| Sep 30, 2021 | 78.13% |
| Jun 30, 2021 | -76.65% |